NUTX · XBRL financial data

Nutex Health financial statements, every quarter

The same tables from 14 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (NUTX's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24†Mar 31, 2024	Q2 FY24†Jul 23, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	62,723	69,669	67,454	—	78,795	257,618	211,789	243,985	267,804	151,679*	216,485	210,752
Gross profit	7,066	13,213	10,157	—	21,917	141,626	118,338	124,924	154,881	—	91,730	141,279
General and administrative	7,795	8,500	8,658	—	9,865	12,748	10,035	12,498	11,297	17,823*	14,380	16,677
Total operating expenses	7,887	39,358	8,708	—	12,254	27,417	37,677	91,245	24,514	15,220*	10,465	19,561
Operating income (loss)	(821)	(26,145)	1,450	—	9,663	114,209	80,661	33,679	130,367	30,918*	81,265	121,718
Interest expense	4,098	4,237	4,444	—	5,381	5,052	6,120	5,678	5,452	4,976*	4,682	4,671
Other income (expense)	53	(328)	241	—	(129)	(43)	(3,325)	(4,269)	(976)	(48)*	(23)	38
Income tax expense (benefit)	(342)	(2,999)	390	—	4,585	8,609	20,410	7,588	27,140	9,286*	13,797	20,768
Net income (loss)	(5,542)	(31,618)	(364)	—	(8,788)	61,696	21,217	(17,697)	55,435	11,834*	46,807	65,842
Earnings per share, basic‡ USD per share	(1.49)	(7.46)	(1.49)	—	(1.72)	11.83	3.74	(2.95)	8.27	1.68*	6.70	9.58
Earnings per share, diluted‡ USD per share	(1.49)	(7.46)	(1.49)	—	(1.72)	11.12	3.33	(2.95)	7.76	—	6.52	9.38
Weighted average shares, basic‡ thousands of shares	4,456	4,504*	325	—	5,100	—	5,667	5,995	6,701	7,063*	6,990	6,871
Weighted average shares, diluted thousands of shares	4,434	—	4,849	—	5,100	—	6,451	5,995	7,178	7,386*	7,179	7,021

‡ Per-share figures and share counts are adjusted for the 1-for-14.925373134328357 stock split (April 2024); filings made before it reported them unadjusted.
‡ Per-share figures and share counts are adjusted for the 1-for-10 stock split (July 2024); filings made before it reported them unadjusted.
† Share count changed about 1/15 in the period ending 2024-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 15x in the period ending 2024-07-23, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (NUTX's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24†Mar 31, 2024	Q2 FY24†Jul 23, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	26,827	22,002	30,006	—	46,909	40,641	84,729	96,733	166,048	185,574	207,347	205,208
Accounts receivable	53,210	58,624	61,533	—	62,745	232,449	295,082	—	—	—	—	—
Inventory	2,683	3,391	2,975	—	2,259	2,850	3,118	2,275	3,158	2,866	4,679	4,207
Prepaid and other current assets	5,645	2,679	1,629	—	4,279	9,996	11,389	19,060	16,586	24,656	18,432	17,635
Total current assets	89,852	90,848	100,358	—	119,795	292,479	401,517	473,025	592,651	538,811	579,649	585,650
Property and equipment, net	85,497	81,388	80,571	—	78,246	77,933	76,431	82,915	82,821	94,581	94,927	95,702
Right-of-use asset	16,712	11,853	11,580	—	11,442	27,872	27,466	27,751	27,354	26,955	26,554	26,150
Goodwill	17,935	17,066	17,066	—	13,919	13,919	13,919	13,919	13,919	13,919	13,919	13,919
Total assets	479,634	398,245	404,284	—	438,489	655,320	761,916	841,028	964,518	918,525	957,318	964,629
Accounts payable	17,599	18,899	17,218	—	10,321	9,614	19,836	—	—	—	—	—
Current portion of long-term debt	19,645	10,809	9,388	—	10,500	14,395	13,635	18,951	18,004	13,336	16,728	8,496
Total current liabilities	67,267	58,313	59,888	—	67,559	154,226	196,179	194,874	185,456	157,911	184,436	117,220
Long-term debt	19,304	26,315	26,308	—	26,802	22,466	21,733	20,463	25,574	29,174	24,261	31,105
Lease liability, non-current	15,874	15,480	15,097	—	14,307	30,617	30,350	30,805	30,423	30,037	29,633	29,223
Total liabilities	374,729	319,139	324,272	—	358,710	466,789	506,649	504,151	526,485	495,088	515,265	457,317
Accumulated deficit	(377,455)	(409,073)	(409,437)	—	(418,589)	(356,976)	(335,759)	(353,456)	(298,021)	(286,187)	(239,380)	(173,538)
Total stockholders' equity	89,928	61,453	63,019	—	60,441	132,438	176,948	235,250	317,166	329,447	346,293	394,316
Total liabilities and equity	479,634	398,245	404,284	—	438,489	655,320	761,916	841,028	964,518	918,525	957,318	964,629
Common shares outstanding (cover page)‡ thousands of shares	4,494	4,994	333	5,066	5,437	5,528	5,566	7,072	7,072	6,968	6,881	6,848

‡ Per-share figures and share counts are adjusted for the 1-for-14.925373134328357 stock split (April 2024); filings made before it reported them unadjusted.
‡ Per-share figures and share counts are adjusted for the 1-for-10 stock split (July 2024); filings made before it reported them unadjusted.
† Share count changed about 1/15 in the period ending 2024-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 15x in the period ending 2024-07-23, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (NUTX's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24†Mar 31, 2024	Q2 FY24†Jul 23, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(5,542)	(31,618)	(364)	—	(8,788)	61,696	21,217	(17,697)	55,435	11,834*	46,807	65,842
Depreciation and amortization	4,746*	4,683*	4,186	—	4,972	5,280*	5,092	5,248	5,003	5,187*	5,492	5,317
Net cash from operating activities	1,968*	(1,776)*	3,051	—	6,789*	53*	50,965	27,257*	99,514*	70,389*	75,518	34,200*
Purchases of property and equipment	—	year only	733	—	617*	395*	64	751*	302*	1,409*	1,201	2,540*
Net cash from investing activities	(3,619)*	866*	(733)	—	(267)*	(3,336)*	(64)	196*	(302)*	(5,072)*	(1,201)	(2,540)*
Proceeds from issuing common stock	—	year only	9,203	—	(1)*	0*	0	0*	0*	0*	—	—
Share repurchases	—	year only	—	—	—	year only	0	0*	—	year only	31,730	18,958*
Proceeds from long-term debt	—	—	2,915	—	—	—	157	—	—	—	—	—
Repayments of long-term debt	—	—	4,388	—	—	—	1,810	—	—	—	—	—
Net cash from financing activities	(4,277)*	(3,914)*	5,687	—	(421)*	(2,986)*	(6,812)	(15,449)*	(29,897)*	(45,791)*	(49,549)	(35,191)*

† Share count changed about 1/15 in the period ending 2024-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 15x in the period ending 2024-07-23, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 7389 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 7389 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Nutex Health	205,208	210,752	34,200*	6.8M	—	Q2 FY26 10-QJun 30, 2026
Andersen Group	175,631	217,658	69,682*	not reported	—	Q2 FY26 10-QJun 30, 2026
Claritev	14,373	257,478	92,671*	16.9M	—	Q2 FY26 10-QJun 30, 2026
Cass Information Systems	228,473	49,943	16,937*	12.8M	—	Q2 FY26 10-QJun 30, 2026
TIC Solutions	362,420	584,347	(9,767)*	218.2M	37.1 quarters	Q2 FY26 10-QJun 30, 2026
CONDUENT	228,000	531,000	7,000*	155.5M	—	Q2 FY26 10-QJun 30, 2026
Liquidity Services	219,751	129,578	31,173*	31.3M	—	Q3 FY26 10-QJun 30, 2026
MediaAlpha	18,677	375,946	21,604*	not reported	—	Q3 FY26 10-QSep 30, 2026
Quinstreet	128,315	373,877*	53,147*	57.1M	—	Q4 FY26 10-KJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.